Logo-apb
Adv Pharm Bull. 2022;12(2): 346-355. doi: 10.34172/apb.2022.033
PMID: 35620329        PMCID: PMC9106962

Research Article

Preparation of Azithromycin Nanofibers as Controlled Release Ophthalmic Drug Carriers Using Electrospinning Technique: In Vitro and In Vivo Characterization

Shiva Taghe 1,2 ORCID, Saba Mehrandish 3 ORCID, Shahla Mirzaeei 1,2 * ORCID

Cited by CrossRef: 7


1- Abadi B, Goshtasbi N, Bolourian S, Tahsili J, Adeli-Sardou M, Forootanfar H. Electrospun hybrid nanofibers: Fabrication, characterization, and biomedical applications. Front Bioeng Biotechnol. 2022;10 [Crossref]
2- Hatamie S, Shih P, Chen B, Hatami N. Carbohydrate Polymers, Polymeric Nano Drugs, and Nanoparticles Are Used for Advanced Drug Delivery and Therapeutics in Ocular Diseases. Polymers for Advanced Techs. 2025;36(2) [Crossref]
3- Omer S, Zelkó R. A Systematic Review of Drug-Loaded Electrospun Nanofiber-Based Ophthalmic Inserts. Pharmaceutics. 2021;13(10):1637 [Crossref]
4- Swarup P, Agrawal G. A Review on Delivery and Bioavailability Enhancement Strategies of Azithromycin. ASSAY and Drug Development Technologies. 2022;20(6):251 [Crossref]
5- Sakpal D, Gharat S, Momin M. Recent advancements in polymeric nanofibers for ophthalmic drug delivery and ophthalmic tissue engineering. Biomaterials Advances. 2022;141:213124 [Crossref]
6- Mostafa D, Hashad A, Abou El-ezz D, Ragab M, Khalifa M. Electrospun PVA nanofiber mat for topical Deflazacort delivery: accentuated anti-inflammatory efficacy for wound healing. Pharmaceutical Development and Technology. 2023;28(9):884 [Crossref]
7- Shaikhi Shoushtari F, Naghshbandy M, Rezaei L, Mehrandish S, Mirzaeei S. Fabrication of Anti-glaucoma Nanofibers as Controlled-Release Inserts for Ophthalmic Delivery of Brimonidine Tartrate: In Vivo Evaluation in Caprine Eye. Adv Pharm Bull. 2024;14(2):378 [Crossref]
8- Sahu D, Pradhan D, Halder J, Biswasroy P, Kar B, Ghosh G, Rath G. Preparation and Characterization of Gatifloxacin-Loaded Polyacrylonitrile Nanofiber for the Management of Dry Eye Infection. J Pharm Innov. 2023;18(2):391 [Crossref]